Cargando…
STAT3 in Tumor-Associated Myeloid Cells: Multitasking to Disrupt Immunity
Myeloid immune cells, such as dendritic cells, monocytes, and macrophages, play a central role in the generation of immune responses and thus are often either disabled or even hijacked by tumors. These new tolerogenic activities of tumor-associated myeloid cells are controlled by an oncogenic transc...
Autores principales: | Su, Yu-Lin, Banerjee, Shuvomoy, White, Seok Voon, Kortylewski, Marcin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032252/ https://www.ncbi.nlm.nih.gov/pubmed/29921770 http://dx.doi.org/10.3390/ijms19061803 |
Ejemplares similares
-
Push and release: TLR9 activation plus STAT3 blockade for systemic antitumor immunity
por: Kortylewski, Marcin, et al.
Publicado: (2014) -
Editorial: Roles of Tumor-Recruited Myeloid Cells in Immune Evasion in Cancer
por: Kusmartsev, Sergei, et al.
Publicado: (2021) -
Cell-selective oligonucleotide STAT3 inhibitor for immunotherapy of human acute myeloid leukemia
por: Zhang, Qifang, et al.
Publicado: (2015) -
IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathway
por: Wang, Lin, et al.
Publicado: (2009) -
Stat3-induced S1PR1 expression is critical for persistent Stat3 activation in tumors
por: Lee, Heehyoung, et al.
Publicado: (2010)